<DOC>
	<DOCNO>NCT00127270</DOCNO>
	<brief_summary>This study design investigate efficacy safety treatment overactive bladder darifenacin administer alone conjunction behavioral modification therapy .</brief_summary>
	<brief_title>Using Behavioral Therapy Combination With Darifenacin Symptoms Overactive Bladder</brief_title>
	<detailed_description />
	<mesh_term>Urinary Incontinence</mesh_term>
	<mesh_term>Enuresis</mesh_term>
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>Darifenacin</mesh_term>
	<criteria>Symptoms overactive bladder Capable independent toileting complete micturition diary Able comprehend English follow study procedure instruction Post void residual &gt; 100ml/sec Urine flow rate ( Qmax ) &lt; 10ml/sec male Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>OAB</keyword>
	<keyword>Overactive Bladder</keyword>
	<keyword>Bladder hyperactivity</keyword>
	<keyword>Urge Incontinence</keyword>
	<keyword>Incontinence</keyword>
	<keyword>Bladder</keyword>
</DOC>